Bernardo Cavallazzi Sebold

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Placebo Controlled

Renal Cell Carcinoma

Top Venues

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, Hejie Li, Xiaosong Liu, Tianfang Wang
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? Current oncology reports 25 (2) (2022)
Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, Hejie Li, Xiaosong Liu, Tianfang Wang
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? Current oncology reports 25 (2) (2022)
Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, Hejie Li, Xiaosong Liu, Tianfang Wang
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? Current oncology reports 25 (2) (2022)
Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, Hejie Li, Xiaosong Liu, Tianfang Wang
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? Current oncology reports 25 (2) (2022)
Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, Hejie Li, Xiaosong Liu, Tianfang Wang
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? Current oncology reports 25 (2) (2022)
Bernardo Cavallazzi Sebold, Guoying Ni, Junjie Li, Hejie Li, Xiaosong Liu, Tianfang Wang
PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? Current oncology reports (2022)